Tetralogy of Fallot

Article written and reviewed by Dr Luca Moretti

Tetralogy of Fallot is a congenital heart defect characterized by a large malalignment ventricular septal defect, right ventricular outflow tract obstruction, an aortic root overriding the interventricular septum, and right ventricular hypertrophy secondary to loading conditions. The classical designation lists four features, but the significance of the malformation lies in their interdependence: the outlet to the lungs is obstructed to a varying degree, while the septal defect allows the right ventricle to contribute directly to aortic output. The amount of blood reaching the lungs, and thus the degree of systemic desaturation, depends mainly on the severity and dynamic component of the obstruction, any contribution from the ductus arteriosus, and the ratio between the resistances of the two circulations. The same anatomical label may therefore describe a severely cyanotic newborn, an infant experiencing hypoxic spells, or a child with initially mild desaturation.

In clinical usage, the international abbreviation TOF, from tetralogy of Fallot, often encompasses very different patients even after repair. Surgery separates the circulations and relieves pulmonary obstruction, but may leave or produce pulmonary valve regurgitation, residual stenoses, scars, and altered ventricular mechanics. The subsequent history therefore concerns a surgically repaired heart defect whose physiology must be assessed individually. A patient with a preserved pulmonary valve and normal right-sided pressures does not have the same profile as one with a large transannular patch, free regurgitation, a dilated right ventricle, and ventricular tachycardia. Documentation of the original anatomy, surgical technique, and every subsequent treatment remains an integral part of the diagnosis throughout life.

Tetralogy belongs to the conotruncal heart defects, but requires assessment distinct from that of other outflow tract malformations. In the form considered here, continuity exists between the right ventricle and the pulmonary arteries, although it may be markedly reduced. Pulmonary atresia with ventricular septal defect, by contrast, fundamentally changes the problem of blood supply to the different pulmonary segments and may require specific vascular reconstructions. Absent pulmonary valve, association with an atrioventricular septal defect, and a double-outlet right ventricular connection also identify important variants that cannot be managed by automatically applying the choices used for tetralogy with the usual pulmonary stenosis.

Advances in cardiac surgery have transformed survival, making it common for patients to reach adulthood. This achievement does not remove the need for surveillance: preventing biventricular dysfunction, choosing when to replace a deteriorated pulmonary valve, and recognizing arrhythmic risk are central issues in contemporary management of Fallot. In the multicenter Pediatric Cardiac Care Consortium cohort, long-term outcomes were studied by linking pediatric surgical data with mortality and transplantation registries; that study documents the value of extended follow-up and the influence of baseline characteristics, without justifying the application of a historical survival percentage to every child operated on today. Prognosis must be assessed by distinguishing perioperative mortality, survival among discharged patients, freedom from reintervention, and functional quality of life.

Etiology, embryonic development, and genetic basis

The origins of tetralogy lie in the formation and alignment of the ventricular outflow tracts. During embryonic development, elongation of the arterial pole, separation of the aortic and pulmonary channels, formation of the semilunar valves, and integration with the ventricles are coordinated processes. The second heart field contributes to growth of the outflow tract, while cardiac neural crest cells participate in the formation and remodeling of structures at the arterial pole. Disturbances of signals regulating proliferation, migration, and differentiation can produce different combinations of conotruncal anomalies. These cellular contributions should not, however, be taken to mean that every case of Fallot reflects a single migration defect: the final phenotype brings together heterogeneous developmental pathways and is influenced by interactions among tissues.

Malalignment of the outlet septum describes an anatomical relationship, not a molecular diagnosis. Anterior and superior displacement of this structure reduces the subpulmonary space and leaves a communication between the ventricles beneath the aortic root. Obstruction also depends on the configuration of the trabeculations and surrounding musculature, the pulmonary valve, and the size of the arterial tree. The embryological description must therefore distinguish the process that generates the arrangement of structures from subsequent changes developing in response to flow and pressure. Right ventricular hypertrophy, for example, is not a fourth independent malformation produced at the same instant as the others, but a myocardial response to hemodynamic conditions.

The genetic basis may involve chromosomal abnormalities, copy-number variations, monogenic causes, or may remain undefined. An apparently isolated heart defect does not exclude a genetic etiology: certain extracardiac manifestations become recognizable only with growth, while some variants show markedly different expressivity among relatives. Clinical assessment considers craniofacial, palatal, skeletal, renal, neurological, and immunological abnormalities alongside the family's reproductive and cardiac history. An etiological diagnosis may change perioperative care and follow-up as much as counseling about recurrence risk. Genetic counseling is therefore part of the person's overall assessment, not merely a nominal addition to the echocardiographic diagnosis.

The 22q11.2 deletion warrants particular attention in conotruncal anomalies. Its identification prompts an assessment that may include calcium metabolism, immune function, palate, feeding, speech, learning, and mental health. In a neonate undergoing surgery, hypocalcemia may contribute to electrical instability or seizures; a significant immune defect requires transfusion and infection-related management agreed upon with specialists. The severity of these problems cannot be predicted from cardiac morphology alone. Conversely, the absence of obvious dysmorphic features does not exclude the deletion, and the presence of a right aortic arch may heighten diagnostic suspicion without constituting genetic proof in itself. Decisions about testing should be accompanied by an explanation of possible results and their limitations.

Sequencing studies have broadened understanding of nonsyndromic forms. In a large series of patients with apparently isolated tetralogy, exome sequencing identified an enrichment of rare variants in NOTCH1 and FLT4. The finding shows that signaling pathways involved in vascular and cardiac development may contribute to the phenotype, but it does not make every variant in these genes automatically pathogenic. Classification requires consideration of frequency in reference populations, variant characteristics, familial segregation, phenotypic compatibility, and any functional evidence. Nor does that study justify using a variant of uncertain significance to predict the severity of stenosis, surgical outcome, or arrhythmic risk in an individual patient.

Intrafamilial variability explains why counseling cannot be limited to searching for another identical case. A relative may have a different malformation, a subtle extracardiac manifestation, or no recognizable signs. Incomplete penetrance and interaction with other factors make deterministic predictions inappropriate in the absence of a defined molecular diagnosis. Conversely, identifying a well-characterized inherited alteration makes it possible to refine reproductive risk and discuss diagnostic options. A negative test does not eliminate empirical risk or exclude mechanisms not yet identified; its significance depends on the technique used and what it actually measures. A microarray, a multigene panel, and an exome are not interchangeable tests.

The distinction between a pathogenic variant and a variant of uncertain significance has practical consequences. An uncertain finding may require reassessment over time, testing of relatives, or targeted investigations, but should not be presented as the established cause of the heart defect. Even a convincing molecular diagnosis may explain predisposition without providing a reliable quantitative prediction of cardiovascular history. The choice of tests should therefore address explicit questions: clarifying a suspected syndrome, identifying extracardiac risks, informing family counseling, or investigating an unexplained isolated form. In adulthood, it is reasonable to revisit genetic assessments performed many years earlier, particularly if they used techniques unable to detect alterations now identifiable.

Maternal factors and environmental factors contribute to the risk of congenital malformations in different ways. Poorly controlled pregestational diabetes, maternal phenylketonuria, and certain teratogenic exposures are examples of relevant conditions in prenatal assessment. An epidemiological association does not, however, allow tetralogy to be retrospectively attributed to a single exposure without specific evidence. A careful obstetric history serves to identify modifiable conditions and organize surveillance in subsequent pregnancies; it does not justify assigning blame. A child with Fallot may be born even in families with no recognizable risk factors, while most of the exposures considered do not inevitably produce this malformation.

Fetal circulation attenuates some consequences of pulmonary obstruction because the lungs do not yet perform gas exchange and the placenta provides oxygenation. This does not mean that anatomy remains unchanged. Valvular and arterial dimensions, relative flows, and the direction of ductal flow may evolve over the course of pregnancy. A diagnosis made in the second trimester therefore requires assessment of the trajectory, especially if the pulmonary outflow tract is very small. The decisive information for delivery is the likelihood that the newborn will have sufficient antegrade pulmonary blood flow after separation from the placenta, rather than merely confirmation of the four classical features.

Prenatal diagnosis also offers an opportunity to integrate anatomy, genetics, and care planning. Fetal echocardiography should assess the connections, dimensions of the pulmonary pathway, aortic arch, and associated anomalies, while obstetric care assesses growth and extracardiac conditions. The American Society of Echocardiography guidelines emphasize the systematic nature of fetal assessment and the need to tailor repeat examinations to the lesion and its potential evolution. Ultrasound cannot exclude every coronary anomaly or predict postnatal physiology perfectly; a reassuring result for a single parameter therefore does not replace neonatal assessment.

Birth planning translates the fetal diagnosis into anticipated care needs. If pulmonary flow appears likely to depend on the ductus arteriosus, the delivery location must allow rapid access to cardiological assessment, prostaglandin, and protected transfer or specialist treatment. When antegrade flow is expected to be adequate, care may be less intensive, but must still provide for postnatal echocardiographic confirmation. A diagnosis of Fallot alone does not require premature delivery or cesarean section: timing and mode of delivery depend on obstetric indications and actual cardiac needs. Counseling should explain that prenatal assessment estimates risk and prepares resources, whereas definitive decisions depend on circulation after birth. This distinction avoids treating a change in the neonatal plan as a diagnostic error when it reflects physiology that has only then become observable.

Prevalence must be interpreted in light of the denominator and ascertainment method. Estimates based on live births differ from those including fetal diagnoses, pregnancy terminations, and intrauterine deaths; classification of forms with pulmonary atresia also affects the results. Major epidemiological reviews of congenital heart disease document geographic and temporal differences in detection that partly reflect access to diagnostic services and registration systems. Tetralogy is one of the major cyanotic congenital heart defects, but its relative frequency among all heart defects must not be confused with the probability that a particular cyanotic newborn has this malformation. The latter depends on the clinical context and alternative diagnoses.

Finally, when describing pathogenesis, it is useful to distinguish the initial lesion from acquired substrate. The conotruncal defect determines preoperative physiology; cyanosis, pressure overload, interventions, and residual lesions then contribute to shaping the myocardium. Ventricular tachycardia occurring decades after repair cannot be explained solely by the gene involved in embryonic development, nor does late right ventricular dilation necessarily reflect the severity of the original anatomical defect. This distinction guides prevention: the congenital cause cannot be changed after birth, whereas duration of overload, treatable complications, and continuity of surveillance are concrete goals of care.

Pathological anatomy and pathophysiology

Anatomical assessment begins with the ventricular septal defect, which is generally large and nonrestrictive. Its subaortic location allows blood to pass between the chambers and provides functional continuity between the left ventricle and the aortic root. The term malalignment defect indicates displacement between septal components; defining its margins, by contrast, specifies the relationship to valves and conduction tissue. A posteroinferior perimembranous rim is not equivalent to an entirely muscular rim. This difference affects suture placement and the risk of injury to the atrioventricular conduction axis during closure. The description must also exclude other communications, particularly muscular defects, that might sustain a significant shunt after an apparently complete repair.

The overriding aorta receives contributions from both ventricles through the defect. Measuring the degree of override describes how far the root is committed to the right ventricle, but planning cannot be reduced to a percentage. The geometry of the route from the left ventricle to the aorta, its relationships to valvular structures, and the feasibility of constructing a wide, nonangulated intracardiac channel all matter. When both great arteries arise predominantly from the right ventricle, the connection is described as double-outlet; Fallot-like physiology may then coexist with a more complex surgical problem of routing left ventricular flow. Segmental analysis prevents hemodynamic similarity from concealing important structural differences.

Right-sided obstruction may involve several levels in the same patient. The infundibular component includes anatomical narrowing and contraction of subpulmonary muscle; the valvular component depends on the number, thickness, mobility, and fusion of the leaflets as well as annular dimensions. The pulmonary trunk and branches may be small or have focal stenoses. An assessment restricted to the valve therefore risks underestimating the disease, whereas attributing everything to the infundibulum may lead to muscle resection that is insufficient to restore adequate outflow. After surgery, the same principle calls for determining whether a high gradient arises from a proximal segment, prosthesis, conduit, or distal pulmonary arterial tree.

The pulmonary arterial bed influences the distribution of flow as well as its overall amount. Stenosis of a branch may cause marked perfusion asymmetry and increase right ventricular work even when the main trunk appears large. Where the ductus inserts near the origin of a branch, the possibility of narrowing in that region must be considered. Dimensions should be indexed to body surface area and interpreted together with vessel continuity, avoiding the use of a single index as a complete description of the circulation. In tetralogy with ventriculopulmonary continuity, small systemic-to-pulmonary collaterals do not automatically play the same role as the major collateral arteries supplying pulmonary territories in atretic forms.

The coronary arteries are especially important because a substantial branch may cross the surface of the right ventricular outflow tract. Injuring it during an incision or compressing it during a percutaneous procedure can have serious ischemic consequences. It is therefore insufficient merely to document normal coronary origins: the course of relevant branches in relation to the reconstruction site must be understood. An anomalous course does not preclude repair, but may alter the approach, incision length, and possible need for a conduit. In an adult who has already undergone repair, imaging must reassess these relationships in the current anatomy, which may have been altered by patches, outflow tract dilation, and repeated procedures.

The relationship between ventricular pressures and flows is fundamental. With a large defect, ventricular systolic pressures tend to equalize; the right ventricle may therefore operate at near-systemic pressure without pulmonary arterial hypertension. The elevated pressure lies upstream of the obstruction, while distal pressure may be low. This distinction is essential when reporting results: a high tricuspid regurgitation velocity estimates right ventricular pressure, but this cannot automatically be called pulmonary arterial pressure when there is stenosis between the ventricle and artery. Confusing the two conditions can lead to entirely erroneous treatment interpretations.

When obstruction is mild, pulmonary blood flow may be relatively preserved and shunting through the defect may include a left-to-right component. So-called pink tetralogy is not a malformation without obstruction, but a presentation in which the balance of flows maintains systemic oxygen saturation with only a slight reduction. In some infants, relatively excessive pulmonary flow can contribute to tachypnea and poor growth; the picture may change as infundibular obstruction increases. For this reason, an initially near-normal saturation does not rule out subsequent evolution toward cyanosis, nor does it justify surveillance based solely on the child's appearance.

When obstruction becomes substantial, however, a larger proportion of systemic venous return reaches the aorta through the defect, producing a right-to-left shunt. Saturation depends on the pulmonary-to-systemic flow ratio, venous saturations, and distribution of intracardiac flows. Two children with anatomically similar stenosis may have different saturations if oxygen consumption, hemoglobin, volume status, or systemic vascular resistance differs. Pulse oximetry findings should therefore be interpreted in relation to perfusion, neurological status, and clinical course. An acute fall in saturation is not merely a change in color: it may indicate a drop in pulmonary output and rapidly compromise oxygen delivery to organs.

A hypercyanotic spell is sustained by a self-reinforcing pathophysiological cycle. Increased infundibular contraction, reduced preload, or decreased systemic vascular resistance may promote blood flow toward the aorta. Hypoxemia causes agitation and hyperpnea, increasing oxygen consumption and the adrenergic response; acidosis and circulatory instability further worsen the situation. Not every desaturation is an infundibular spell: shunt obstruction, ductal closure, respiratory disease, and arrhythmias must be considered according to context. Recognizing this mechanism nevertheless explains why calming the child, improving filling, and supporting systemic pressure may be physiologically appropriate measures.

In the most obstructive form, the ductus arteriosus may provide an essential fraction of pulmonary flow. Its constriction after birth reduces that contribution and reveals a dependence previously masked by fetal circulation. Suspected ductal dependence requires prompt stabilization and specialist assessment; extreme cyanosis need not be awaited, because hypoperfusion and acidosis may precede collapse. Conversely, tetralogy with adequate antegrade flow does not necessarily require maintaining ductal patency. Physiology must be demonstrated and reassessed, rather than automatically associating every diagnosis of Fallot with prolonged prostaglandin infusion.

Intracardiac repair changes the hemodynamic system: the patch closing the defect directs left ventricular blood to the aorta, while enlargement of the pulmonary pathway reduces right ventricular afterload. If a patch crosses the annulus, valve competence may be compromised and the right ventricle transitions from predominantly pressure loading to diastolic volume loading. Regurgitant volume depends on residual orifice area, pulmonary vascular compliance, diastolic pressures, and the duration of diastole. Free regurgitation therefore does not produce the same backward volume in every patient. Its cumulative consequence is remodeling of a chamber whose regional function may already have been affected by surgery.

Right ventricular remodeling encompasses changes in volume, shape, mass, contractility, and coordination. An aneurysmal outflow tract may contribute to measured volume without providing effective contractile output; the free wall and septum may activate at different times because of right bundle branch block. Ejection fraction describes the overall change in volume, but alone cannot distinguish good forward output from a high total ejection in the presence of substantial valvular recirculation. Volumes, flows, and function must therefore be interpreted together. A reduction in volume following pulmonary valve replacement is likewise a favorable mechanical outcome, but does not automatically establish the disappearance of fibrosis or arrhythmic risk.

Restrictive right ventricular physiology describes filling limited by reduced compliance; late-diastolic antegrade pulmonary flow associated with atrial contraction, interpreted in the appropriate context, may be a sign of it. In the early postoperative period, a poorly compliant chamber may require high filling pressures and prolonged intensive care support. In the longer term, its relationship with volumes, regurgitation, and performance is more complex: reduced compliance may limit dilation while increasing venous pressure. It is therefore incorrect to regard every restrictive Doppler sign as protective or as unequivocal evidence of advanced failure; it must be related to atrial function, congestion, and exercise.

Ventricular interdependence makes repaired Fallot potentially a biventricular disease. Right ventricular dilation and pressure alter septal position and movement, while the pericardium, activation sequence, and venous return affect left ventricular filling. Left ventricular dysfunction may also reflect previous periods of cyanosis, perioperative injuries, aortic valve disease, or acquired conditions. Declining left ventricular function must not be dismissed as an incidental finding, because it may have prognostic importance and alter tolerance of arrhythmias. Treatment of a significant pulmonary lesion must therefore be considered within an assessment of both pumps, rather than being limited to normalization of right ventricular volume.

The aortic root may remain dilated after repair. Preoperative flow overload and properties of the aortic wall contribute, but dilation, progression, and risk of complications are not synonymous. Adult series document wide variability in dimensions and a rate of dissection much lower than might be suggested by the mere presence of a large aorta. Surveillance should measure the root and ascending aorta reproducibly, assess regurgitation, and identify hypertension or other concomitant conditions. The risk profile of more aggressive inherited aortopathies should not automatically be extrapolated to Fallot.

The variant with an absent pulmonary valve combines rudimentary valvular tissue, significant regurgitation, and dilation of the pulmonary arteries. In this setting, the relationship to the airways becomes crucial: compressed or malacic bronchi can cause respiratory distress, infections, and difficulties in weaning from ventilation even after satisfactory cardiac repair. The condition cannot simply be described as Fallot with more regurgitation. Likewise, an associated atrial communication may alter saturation or provide a route for decompression under particular conditions, but must not be regarded as a required component of tetralogy. Additional anatomical features must be specified because each detail may change the balance of the repair.

Clinical manifestations and patient assessment

The neonatal history first establishes how the heart defect was identified: fetal diagnosis, pulse oximetry screening, murmur, cyanosis, or deterioration after birth. Gestational age, weight, need for ventilation, saturation trends, prostaglandin use, and extracardiac anomalies are relevant. Initially acceptable saturation followed by worsening over subsequent days suggests reassessing ductal contribution and progression of obstruction. Information about delivery and respiratory adaptation helps distinguish cardiac involvement from concomitant pulmonary disease. An absence of alerts during screening does not exclude minimally cyanotic forms, in which the defect may become apparent at a later examination. Screening is a tool for detection, not a complete anatomical classification.

In an infant, describing feeding provides valuable functional information. Time required to feed, pauses, sweating, development of a bluish color, and difficulty recovering after crying should be related to weight gain. Not all slow feeding is hemodynamic in origin: prematurity, oromotor dysfunction, palatal anomalies, or reflux may contribute. Nevertheless, a change from usual behavior may precede documented desaturation. It is useful to ask family members whether the child seems different on waking, during defecation, when febrile, or after vomiting, because agitation and reduced circulating volume can rapidly alter an already fragile balance.

The history of hypoxic spells must distinguish a transient increase in cyanosis from an episode involving neurological or circulatory compromise. The trigger, duration, hyperpnea, irritability, hypotonia, loss of consciousness, any seizure-like movements, and manner of resolution should be reconstructed. An account of a child who becomes progressively bluer and then suddenly less responsive is especially important: less agitation does not necessarily mean improvement. Episode frequency also matters, but a single severe spell may change the treatment plan. Video footage already available may aid reconstruction, without delaying care during an ongoing event.

In an older child who has not yet undergone repair, squatting after exertion is a characteristic adaptation, now less common where repair is performed early. Increased systemic vascular resistance and changes in venous return may reduce right-to-left shunting and improve tolerance. This observation has physiological significance, but its absence does not exclude the diagnosis. Activity limitations may be described as a preference for quiet games, a need to stop, or difficulty keeping up with peers. Over time, children may unconsciously adapt their habits to the heart defect, making a general question about feeling well relatively uninformative.

In adolescents and adults who have undergone repair, the surgical history must identify the age and type of repair, any palliation, use of transannular patches, conduits and prostheses, residual septal defects, reinterventions, and complications. External scars may suggest previous approaches but cannot reconstruct the internal anatomy. Operative records, original images, and reports should be retrieved whenever possible. A previous systemic-to-pulmonary shunt may explain pulse differences or problems in an arterial branch; a conduit does not grow with the patient and may calcify; and a prosthesis identifies a specific infection-risk profile and surveillance pathway. The name of the most recent operation does not replace the full sequence of procedures.

Exertional symptoms should be compared with previous performance and everyday demands. Dyspnea, fatigue, reduced walking speed, longer recovery, or withdrawal from sports may indicate a loss of reserve before signs of heart failure appear at rest. It is useful to distinguish muscular, respiratory, and cardiovascular limitations while considering anemia, obesity, deconditioning, and pulmonary disease. Reduced activity can mask progression of a valvular lesion: patients remain apparently asymptomatic because they no longer reach the level of exertion that would provoke symptoms. Comparison with an earlier cardiopulmonary exercise test makes this phenomenon easier to identify.

Palpitations, dizziness, and syncope require precise characterization. Abrupt onset and termination suggest paroxysmal tachycardia, but subjective perception does not establish the mechanism. Syncope during activity, preceded by palpitations or lacking a clear vasovagal prodrome, is particularly concerning in repaired Fallot. Duration, injury, recovery, medications, dehydration, and family history are important, without automatically attributing every loss of consciousness to ventricular tachycardia. An atrial arrhythmia may be poorly tolerated if ventricular function is impaired or filling depends heavily on atrial contraction. Identifying the responsible rhythm must be accompanied by assessment of hemodynamic lesions that may promote it.

Symptoms of congestion include rapid weight gain, edema, abdominal distension, early satiety, and decreased appetite. At advanced stages, signs of hepatic or renal involvement may appear, but their late appearance does not mean ventricular dysfunction is recent. The history must cover fluid intake, changes in diuretic treatment, infections, treatment adherence, and possible precipitating factors. In adults, common cardiovascular risks must also be assessed: hypertension, diabetes, dyslipidemia, and smoking may coexist with congenital heart disease and change the significance of chest pain or dyspnea. A congenital diagnosis does not protect against acquired disease.

The physical examination begins with general condition, breathing, perfusion, and oxygen saturation, interpreted in relation to baseline values and anatomy. Central cyanosis involves mucous membranes and the tongue; coloration of the extremities alone may reflect peripheral vasoconstriction. Heart rate, blood pressure, capillary refill, and temperature complete the assessment. In children, weight, length, and head circumference must be considered in relation to the growth trajectory; in adults, weight trends and signs of frailty are useful. A measurement obtained during intense crying is not equivalent to one obtained at rest, but desaturation provoked by agitation has clinical significance and must not simply be dismissed as artifact.

Before repair, an accentuated right ventricular impulse may be palpable. The systolic ejection murmur arises mainly from obstructed pulmonary outflow, whereas the large ventricular septal defect may generate little gradient and therefore may not produce the loud murmur typical of a small restrictive communication. This apparent discrepancy is instructive: murmur intensity does not directly measure anatomical severity. During a spell, markedly reduced flow through the outflow tract can make the murmur shorter or less audible even as the child deteriorates. The pulmonary component of the second heart sound may be difficult to hear; a continuous murmur suggests an extracardiac flow source, such as a ductus or shunt, to be correlated with echocardiography.

After repair, a parasternal diastolic murmur may suggest pulmonary regurgitation, but its absence does not exclude a severe lesion, especially when pressures equalize rapidly. A systolic murmur may result from residual stenosis, a conduit or prosthesis, or increased flow. Auscultation findings must be related to jugular venous distension, hepatomegaly, edema, and the precordial impulse. Significant tricuspid regurgitation may produce prominent venous waves and a pulsatile liver. Blood pressure should be measured in an appropriate limb, considering previous palliative procedures; a pulse difference may have a surgical explanation and must not be interpreted without reviewing the anatomical history.

Uncorrected chronic cyanosis may be associated with digital clubbing and secondary erythrocytosis. Elevated hemoglobin is a compensatory response to hypoxemia and is not, by itself, an indication for phlebotomy. Headache, dizziness, or fatigue requires assessment of hydration, iron status, saturation, and other causes; iron deficiency can impair oxygen transport even when the absolute hemoglobin level appears high. The examination should look for focal neurological signs and infection when warranted by the context. These problems are less common after timely repair but remain relevant in patients with delayed access to care or residual lesions maintaining a right-to-left shunt.

Respiratory assessment is particularly important in the absent pulmonary valve variant and in patients with previous prolonged intubation. Stridor, persistent wheezing, asymmetric breath sounds, and recurrent infections may indicate vascular compression or airway abnormalities. Dyspnea should not automatically be attributed to pulmonary regurgitation merely because it is present. Likewise, scoliosis, thoracic sequelae, and reduced muscle strength may contribute to functional limitation. An integrated approach avoids both undertreating a significant cardiac lesion and proposing reintervention with the unrealistic expectation that it will resolve every respiratory symptom.

Neurodevelopment is assessed throughout the care pathway. Difficulties involving attention, executive functions, language, motor skills, or learning may emerge as school demands increase, even when cardiac function is good. Assessment considers genetic conditions, family environment, prematurity, perioperative exposures, and history of hypoxemia. In adolescence, anxiety, body image, self-management of treatment, and social participation become important. The AHA statement on neurodevelopment proposes surveillance based on risk and individual needs; applied to Fallot, this principle enables early identification of difficulties that routine echocardiography cannot detect.

Listening to the patient complements instrumental findings. Some people minimize symptoms for fear of further interventions, while others excessively restrict activity after years of family precautions. Asking about specific goals, such as working, participating in sports, or planning a pregnancy, connects cardiological assessment to real decisions. Functional status is not equivalent to the number of hospitalizations alone: independence, sleep quality, concentration, and continuity of education or employment describe dimensions that may be impaired even without a major event. This information helps tailor the intensity of follow-up and supportive interventions.

Diagnosis, imaging, and risk stratification

Echocardiography is the central examination for confirming the diagnosis in newborns and children. Analysis proceeds through venous, atrioventricular, and ventriculoarterial connections, describing the defect, degree of override, right ventricular outflow tract, pulmonary valve, and branches. It must also document ventricular function, atrioventricular valves, aortic arch, ductus arteriosus, and any additional communications. A report useful for decision-making does not merely state that tetralogy is present: it specifies which structures obstruct flow, whether the pulmonary circulation is continuous, whether ductal dependence exists, and whether an associated anomaly alters the repair. Diagnostic quality depends on the completeness of the questions addressed, not the number of images stored.

Outflow Doppler must be interpreted in the context of physiology. A high gradient demonstrates acceleration, but extremely severe stenosis with very low flow may not generate the expected velocity. Furthermore, with multiple levels of obstruction, the continuous-wave signal summarizes a sequence of accelerations and does not by itself locate each component. Estimation of right ventricular pressure from tricuspid regurgitation must be compared with systemic pressure, envelope quality, and intervening lesions. A large defect may allow nearly equal ventricular pressures and make the interventricular gradient relatively uninformative about obstruction severity. Hemodynamic quantification therefore requires prior anatomical interpretation.

Valvular dimensions are measured consistently and compared with references appropriate for age and body size. The pulmonary annular z-score helps describe hypoplasia but is not a universal threshold that automatically dictates valve preservation or a transannular patch. Leaflet mobility, commissural morphology, effective area after treatment, and residual gradient are equally important. Different nomograms may also yield different values for the same measurement. Surgical decisions therefore integrate preoperative imaging, intraoperative findings, and the hemodynamic result, rather than presenting an echocardiographic measurement as a guarantee of the final technique.

Echocardiographic coronary assessment should visualize the origins and proximal course whenever technically feasible. An incomplete image is not evidence of normality. If uncertainty could change the intervention, an additional modality is selected according to patient stability, required resolution, and availability. The same reasoning applies to distal pulmonary branches or complex vascular relationships. Additional examinations need not be multiplied in a child with clearly defined anatomy and adequate images; when anatomy is ambiguous, proceeding without clarifying a relevant detail may be riskier than targeted further investigation. The diagnostic strategy is therefore selective but must be sufficiently comprehensive.

After repair, echocardiography assesses residual lesions and their consequences: shunting across the patch, subvalvular or arterial stenosis, pulmonary and tricuspid regurgitation, ventricular function, right-sided pressure, and the aorta. Color Doppler can identify regurgitation, but the visual extent of the jet depends on settings and flow conditions. Pulmonary regurgitation severity is estimated by integrating signal duration and characteristics, flow reversal in the branches, ventricular dimensions, and data from other modalities. A single parameter is insufficient, particularly in broad and irregular outflow tracts. Multimodality recommendations for repaired Fallot organize precisely this integration, assigning a specific question to each examination.

Cardiovascular magnetic resonance is the reference method for reproducible quantification of right ventricular volumes and flows in most suitable adolescents and adults. It measures indexed end-diastolic and end-systolic volumes, mass, ejection fractions, and outputs; phase-contrast imaging permits calculation of pulmonary regurgitation and flow distribution between branches. The examination must also include the left ventricle, aorta, outflow tract, conduits, and vascular anatomy. Its value lies not simply in obtaining a more precise number, but in distinguishing a chamber enlarged by volume overload from one with a high end-systolic volume and impaired emptying.

Measurement quality determines the meaning of longitudinal comparisons. Endocardial contours, inclusion of trabeculations, selection of basal slices, arrhythmias, and artifacts may affect volumes. Indexing also requires caution in people with marked weight changes, because altered body surface area can change the indexed value without a corresponding change in absolute volume. When an invasive decision depends on modest progression, consistency of technique and physiological plausibility should be verified, comparing the images as well as the reports. The clinical value of a longitudinal series increases when acquisitions follow comparable protocols and are interpreted by operators experienced in congenital heart disease.

Late gadolinium enhancement, meaning delayed enhancement after gadolinium administration, enables recognition of areas of focal fibrosis. In repaired Fallot, enhancement may occur in surgical regions and elsewhere in the myocardium; its extent and left ventricular involvement may contribute to prognostic assessment. In the prospective cohort studied by Ghonim and colleagues, fibrosis data were combined with function, exercise capacity, biomarkers, and arrhythmic history to estimate risk. This finding supports a multiparametric approach but does not justify treating any enhancement as an automatic indication for a defibrillator. Acquisition technique, study population, and availability of validation influence whether a model is applicable to an individual patient.

CT angiography provides high anatomical resolution for coronary arteries, pulmonary arteries, conduits, calcifications, and relationships to the sternotomy and airways. It is particularly useful when planning transcatheter valve implantation in a native or reconstructed outflow tract, where dimensions and shape vary throughout the cardiac cycle. Assessment includes landing zones, proximity to the aorta, coronary course, and possible interference with branches. Radiation, contrast agent, and renal function are considered alongside expected benefits using appropriate protocols. CT does not automatically replace magnetic resonance for every functional question, but may be decisive when device geometry or extracardiac relationships are the main concern.

Cardiac catheterization is reserved for questions requiring invasive measurements, clarification unavailable from imaging, or a procedure performed at the same session. It allows measurement of pressures, gradients, saturations, and flows, checking discordant noninvasive estimates. In a patient with high right ventricular pressure, it can distinguish outflow obstruction from increased pulmonary vascular resistance; in residual septal defects, it can help determine shunt magnitude. Sedation changes resistance and flow, so examination conditions must be recorded. A hemodynamic measurement must not be interpreted separately from clinical status and the technique by which it was obtained, particularly when used to justify a major intervention.

The electrocardiogram documents rhythm, atrioventricular conduction, and QRS duration and morphology. Right bundle branch block is common after repair, but its significance varies with surgical history and remodeling. Progressive QRS widening may signal changes in the substrate, whereas a single value does not fully describe risk. The historical multicenter study by Gatzoulis demonstrated associations between electrical markers, hemodynamic lesions, and late events; modern cohorts subsequently broadened assessment to ventricular function and imaging. A duration below a historical threshold does not rule out dangerous tachycardia, just as a duration above it does not inevitably identify who will experience an event.

Rhythm monitoring is tailored to the question: short-term Holter recording may quantify frequent ectopy, while sporadic symptoms call for longer recordings or patient-activated devices. Nonsustained ventricular tachycardia carries different weight depending on symptoms, rate, duration, ventricular function, and other findings. A negative recording during a symptom-free interval does not exclude paroxysmal arrhythmia. In device recipients, interrogation allows analysis of episodes and therapies, but automatic classifications must be checked against the actual rhythm. Assessment must not be reduced to counting premature beats: the goal is to understand the substrate and identify events that change management.

Cardiopulmonary exercise testing measures oxygen consumption, ventilation, chronotropic response, blood pressure, and saturation during standardized exertion. Interpretation considers motivation, protocol, age, body mass, medications, and the degree of effort achieved. Peak oxygen consumption may decrease because of cardiac dysfunction, ventilatory limitation, or deconditioning; integrated analysis helps distinguish these contributions. The trajectory is particularly important during follow-up: a documented decline may reveal worsening that the patient has compensated for by reducing activity. Not every low value means that the valve must be replaced immediately, but ignoring it because there are no symptoms at rest would omit a substantial part of the assessment.

Biomarkers and laboratory tests complete the assessment when they address clinical questions. Natriuretic peptides may support evaluation of hemodynamic stress; blood count, iron status, renal function, and liver function help identify aggravating causes or consequences of disease. A single normal result does not exclude significant valvular lesions, and an elevated result does not locate them. In patients with prostheses and fever, blood cultures and infectious disease assessment take precedence over a purely hemodynamic interpretation. Tests are therefore selected according to symptoms, medications, and physiological stage, avoiding indiscriminate panels and follow-up limited exclusively to cardiac imaging.

Arrhythmic risk stratification brings together information describing different aspects of vulnerability. Right and left ventricular function, pressures, scars, previous atrial arrhythmias, ventricular tachycardia, syncope, and functional capacity are not interchangeable variables. In INDICATOR, right ventricular hypertrophy, ventricular dysfunction, and a history of atrial tachyarrhythmia were associated with the composite endpoint of death or sustained ventricular tachycardia. This finding supports moving beyond assessment based only on pulmonary regurgitation or QRS duration, but remains an observational association. A score informs specialist discussion; it does not remove the need to establish whether the patient resembles the population in which it was developed.

An electrophysiological study can establish inducibility and reentry substrates when clinical risk warrants invasive investigation. Mapping identifies areas of slow conduction bounded by nonexcitable structures such as valve annuli, patches, and scars. The presence of an anatomical isthmus does not mean that every patient has clinical tachycardia, but its characterization may guide ablation and planning for reintervention. Contemporary recommendations reserve this assessment for selected situations, including discussion before pulmonary valve replacement where new material might make an area less accessible. The examination is not a universal screening test to be performed automatically in every adult after repair.

Discrepancies between examinations must be resolved before assuming that they represent rapid biological progression. Echocardiography may show high right ventricular pressure while magnetic resonance documents volumes that are not particularly large: this pattern is consistent with predominantly pressure overload and not necessarily an error. Conversely, a markedly dilated chamber with apparently preserved ejection fraction may sustain a high total stroke volume but less satisfactory net output because of pulmonary recirculation. Comparing flows, volumes, and clinical findings allows a coherent explanation. When a discrepancy remains unresolved and would change the treatment indication, reviewing the images or performing a targeted invasive measurement is preferable to arbitrarily choosing the most reassuring finding.

The initial differential diagnosis includes other cardiac and respiratory causes of cyanosis. Critical pulmonary stenosis with intact septum, transposition of the great arteries, tricuspid atresia, and anomalous venous connections have different physiology and urgency; echocardiography distinguishes them by their connections. In adults after repair, the differential question is chiefly the cause of symptoms: pulmonary regurgitation or stenosis, arrhythmia, left ventricular dysfunction, ischemia, pulmonary embolism, and respiratory disease may produce similar manifestations. Congenital anatomy informs probabilities but does not justify excluding common acute conditions. The final diagnosis must explain the entire clinical presentation, not merely confirm a previously known lesion.

Treatment, follow-up, and prognosis

Initial stabilization is guided by physiology and clinical severity. In newborns with probable ductal dependence, prostaglandin E1 maintains or may restore pulmonary flow through the ductus while monitoring and definitive treatment are arranged. Ventilation, temperature, glucose, acid-base balance, and perfusion are assessed together; the infusion requires vigilance for effects such as apnea and hypotension. Oxygen may improve the respiratory component of hypoxemia but cannot overcome critical mechanical obstruction. Transfer to a center capable of neonatal treatment should be organized while the infant is stabilized, without waiting for an exceedingly detailed anatomical diagnosis before every essential intervention.

During a hypercyanotic spell, stimulation and agitation are reduced, oxygenation is supported, and conditions favoring improved pulmonary blood flow are promoted. The knee-chest position may increase systemic vascular resistance; volume depletion is corrected when present. Sedation, drugs that attenuate the adrenergic response, and vasoconstrictor support are used by the team according to blood pressure, heart rate, and severity. Airway management and anesthesia require particular attention because an abrupt fall in systemic vascular resistance may aggravate shunting. Refractory spells demand rapid escalation to intensive strategies and an intervention ensuring stable pulmonary blood supply. Drug treatment is a bridge, not a definitive anatomical solution.

The timing of repair balances prevention of hypoxemia, somatic growth, anatomy, and operative risk. The AATS consensus considers complete repair between three and six months reasonable in an asymptomatic infant. In symptomatic neonates, both primary repair and initial palliation may be appropriate; prematurity, low birth weight, small pulmonary branches, and comorbidities influence the choice. These recommendations provide a decision-making framework, not a rigid deadline independent of the clinical picture. A child with spells, progressively inadequate saturation, or impaired growth should not wait until the planned age for elective repair solely to meet a conventional interval.

The choice between primary repair and a staged strategy cannot be resolved solely by comparing the duration of the initial hospitalization. Palliation may reduce the burden of neonatal treatment but entails an interval with an artificial pulmonary blood supply and further procedures. Early repair immediately eliminates the cyanotic intracardiac shunt but may be more complex in fragile neonates. In Goldstein's multicenter cohort, adjusted comparisons showed early advantages for some outcomes with the staged strategy and cumulative advantages, including fewer reinterventions, with primary repair, without a statistically demonstrated overall mortality difference. Its observational nature and anatomical differences preclude concluding that either strategy is universally superior.

A systemic-to-pulmonary shunt creates a source of blood flow independent of the obstructed outflow tract. Its modified form uses a vascular graft and requires balancing adequate supply against the risk of excessive flow, diastolic steal, or overload. Size, site, and relationship to the pulmonary branches influence the result. Thrombosis, stenosis, and arterial distortion are possible complications, so discharge instructions must clearly address changes in color, feeding, and breathing. The usual continuous murmur does not exclude every deterioration of the shunt, and its disappearance together with desaturation is a particularly alarming sign. The plan must already provide for reassessment and subsequent repair.

Right ventricular outflow tract stenting maintains an open antegrade pathway and may promote somatic and pulmonary arterial growth before repair. Feasibility depends on anatomy, access, stability, and relationships to the valve. In Quandt's comparative series, branch growth after stenting was favorable compared with shunting in the population studied, but the nonrandomized comparison does not eliminate patient selection. The procedure may require redilation and necessitates surgical management of the stent at definitive repair; crossing the annulus may compromise the possibility of preserving it. The choice must therefore consider the subsequent treatment pathway as well as the immediate improvement in saturation.

Ductal stenting is another option when the ductus provides a usable source of pulmonary blood flow. Its morphology, tortuosity, insertion into the branches, and the ability to cover the entire portion liable to constrict determine complexity. It is not equivalent to infundibular stenting: the former preserves an extracardiac systemic-to-pulmonary communication, while the latter increases flow from the right ventricle. Balloon valvuloplasty may be useful when anatomy includes a favorable valvular component, but it does not necessarily resolve marked muscular stenosis. These alternatives are considered alongside surgery, avoiding the assumption that a pathway is less invasive simply because it begins with catheterization: the total number of procedures, reliability of flow, and individual risks matter.

In complete repair, closure of the defect must direct left ventricular blood toward the aorta without obstruction and without injuring conduction or valvular structures. Right ventricular outflow obstruction is relieved by treating the musculature, valve, and any arterial narrowings. A transatrial and transpulmonary approach may limit the ventricular incision, whereas certain anatomies require more extensive direct access. The desired result combines minimal residual obstruction, good pulmonary valve competence, and preservation of myocardial function. None of these goals should be pursued in isolation: a competent but excessively stenotic valve leaves harmful pressure loading, while effective decompression achieved at the cost of major regurgitation transfers the problem into long-term follow-up.

Valve preservation includes techniques tailored to leaflet and annular morphology. Commissurotomy or other mobilization procedures may enlarge the opening while preserving some competence, but feasibility depends on the available tissue and geometry. Blais's cohort associated valve-sparing procedures with better long-term outcomes and less need for pulmonary valve replacement than transannular patching, even after adjustment for measured differences. The finding supports preservation when appropriate, without proving that every annulus must be preserved at any cost. Initial anatomy, surgical era, and unmeasured factors remain potential confounders.

A transannular patch remains necessary when the annulus or valve cannot provide adequate outflow with conservative techniques. Reconstruction may include methods intended to limit regurgitation, but their durability must be assessed over time and not assumed from immediate echocardiography. If a coronary artery crosses the usual incision site, the surgeon alters the route or uses an alternative reconstruction, sometimes a conduit. A conduit provides a defined, valved pathway but introduces issues of growth, degeneration, and future reinterventions. The chosen technique therefore represents an individualized anatomical compromise, which must be clearly documented for those caring for the patient in subsequent years.

Intraoperative assessment and early postoperative assessment seek residual defects, fixed obstruction, significant regurgitation, regional wall-motion abnormalities, and coronary problems. A gradient may have a dynamic component and depend on loading conditions, but significant anatomical obstruction should not be excused as inevitable. In the following hours, right ventricular function, venous pressure, rhythm, perfusion, and lactate guide support. Managing a poorly compliant ventricle requires a delicate balance between adequate filling and congestion; loss of atrioventricular synchrony may reduce output. Persistent low output should prompt investigation for a correctable cause rather than indiscriminate escalation of inotropic drugs.

In a pathway involving temporary palliation, growth of the pulmonary branches and the child is not, by itself, enough to determine when to proceed to repair. Reliability of the flow source, need for repeat dilations, saturation trends, and the balance between the benefits of waiting and interstage risk must be considered. Improved saturation after stenting may allow feeding and growth but does not make a solution intended as a bridge permanent. Planning repair in advance reduces the risk of leaving the patient exposed to increasingly inadequate palliation. When new symptoms develop, the device or shunt must be checked rather than automatically attributing deterioration to normal growth. Antithrombotic treatment is also individualized according to implanted material, age, and clinical conditions.

Discharge after repair marks the beginning of recovery, not the end of care. Feeding, wound healing, breathing, and growth are reassessed together with echocardiography. Parents must understand residual findings, treatments that are actually needed, and signs requiring contact with the center. Medication duration is not uniform: diuretics prescribed after surgery may be tapered as congestion resolves, while other therapies depend on specific lesions or arrhythmias. Every change should be linked to a goal and reassessment. A clear plan prevents both premature discontinuation of useful care and continuation for years of treatment started for a need that has since resolved.

Lifelong follow-up is tailored to age, residual lesions, and physiological stage. Clinical examination, electrocardiography, and echocardiography are combined with magnetic resonance, cardiopulmonary exercise testing, and rhythm monitoring at appropriate intervals. A stable condition may permit less frequent visits, but not abandonment of surveillance; changes in symptoms or measurements require earlier assessment. Serial documentation should record the reasons for decisions, including the decision to observe. During adolescence, transition to adult congenital heart disease services must be prepared gradually, ensuring patients understand their diagnosis, operations, prostheses, medications, and how to access care.

Pulmonary valve replacement is considered when regurgitation or stenosis causes clinically or ventricularly significant consequences. The 2025 ACHD recommendations advise treatment in symptomatic patients with at least moderate pulmonary valve dysfunction. In asymptomatic patients, decisions integrate functional deterioration and multiple indicators: indexed right ventricular end-systolic volume above 80 mL/m², right ventricular end-diastolic volume at least twice that of the left ventricle, right ventricular ejection fraction no greater than 46%, left ventricular ejection fraction no greater than 50%, and a progressive decline in exercise capacity. The presence of at least two of these findings, together with at least moderate valvular disease, supports the reasonableness of intervention. These criteria require reliable measurements and specialist discussion.

The definition of moderate pulmonary valve dysfunction used in the 2025 ACHD algorithm includes regurgitation with a magnetic resonance regurgitant fraction of at least 25%, or outflow obstruction resulting in right ventricular systolic pressure exceeding two-thirds of systemic pressure. Regurgitant fraction expresses the ratio of backward to forward volume and must come from a technically reliable acquisition. The obstructive component instead requires a pressure estimate consistent with the anatomy. A patient with a mixed lesion may have important consequences without extreme values of either component: assessing regurgitation and stenosis separately risks underestimating their combined burden. With progressive systolic dysfunction, multidisciplinary discussion should therefore consider the interaction of loads rather than necessarily waiting for one parameter alone to reach an exceptionally high value.

Historical volume thresholds derive in part from studies on the potential for ventricular normalization after replacement. Oosterhof and colleagues observed decreases in volumes after intervention and identified preoperative values associated with subsequent dimensional normalization. This goal is not equivalent to demonstrated prevention of sudden death and does not establish a biological threshold beyond which all benefit disappears. The figure of 160 mL/m², often referring to right ventricular end-diastolic volume, should therefore not be used as the sole decision switch. Pressure, end-systolic function, symptoms, exercise, arrhythmias, and temporal trends allow differentiation of situations that a similar end-diastolic volume would make appear identical.

The outcome evidence for pulmonary valve replacement has evolved. In the registry analyzed by Bokma in 2023, patients undergoing replacement, compared using propensity scores with untreated patients, had a lower risk of the composite outcome of death or sustained ventricular tachycardia. This finding matters because it goes beyond simple remodeling, but remains observational and does not demonstrate identical benefit at every stage of disease. Replacement that is too late may fail to reverse an advanced substrate; replacement that is very early introduces a prosthesis sooner, with a need for surveillance and potentially further procedures. Decisions seek an individual balance between damage from persistent loading and the cumulative burden of interventions.

The choice between surgery and catheter-based treatment depends on outflow anatomy, dimensions, calcifications, the presence of a conduit or bioprosthesis, vascular access, and the need to correct other lesions. Surgery permits simultaneous treatment of aneurysms, complex stenoses, residual defects, or a selected tricuspid valve lesion. The transcatheter approach avoids repeat sternotomy in suitable patients, but requires stable anchoring and careful assessment of neighboring structures. A valve-in-valve procedure uses a previous prosthesis as the implantation site, with potential limitations on the final orifice. Technical availability of a device is not equivalent to a clinical indication for intervention and does not replace assessment of expected benefit.

Coronary compression is one of the risks that must be excluded when planning transcatheter treatment. Expansion of a system may interfere with a nearby coronary artery or alter its relationship with the aorta; imaging and, when relevant to the device platform and anatomy, invasive assessment during trial expansion contribute to safety. The absence of an anomalous coronary artery at birth does not eliminate the problem, because current spatial relationships are what matter. In large native outflow tracts, self-expanding devices require specific geometric selection. Not every reconstructed tract offers a suitable implantation site, and not every available valve can be used under the same conditions.

New pulmonary valve platforms have expanded the treatable population, but their very long-term durability remains an open question. At three- to five-year follow-up in the Harmony cohort, results documented persistent valve competence and favorable remodeling in selected patients. This horizon is useful for evaluating midterm performance, but does not cover the decades ahead for many young people or constitute a randomized comparison with surgery. Endocarditis, obstruction, degeneration, and the need for another procedure remain matters for discussion. Selection of the first prosthesis must therefore also consider treatment options for any future dysfunction.

Chronic drug therapy addresses specific indications but does not correct mechanically significant pulmonary regurgitation. Diuretics relieve congestion; medications for left ventricular dysfunction, hypertension, or arrhythmias are chosen according to the relevant problem. There is no evidence that indiscriminate prescription of a neurohormonal drug prevents progression of every dilated right ventricle after Fallot repair. The small randomized APPROPRIATE trial of ramipril explored functional parameters in stable patients, without proving a mortality reduction or providing a basis for replacing indicated valvular intervention with medical therapy. Favorable surrogate endpoints must not be presented as universal prognostic benefit.

Atrial arrhythmias are treated with consideration of hemodynamic stability, duration, thromboembolic risk, and substrate. Rhythm control may be particularly valuable when loss of atrial contraction compromises right ventricular filling. Urgent cardioversion is necessary in instability; in cases amenable to planned treatment, anticoagulation and identification of the mechanism are addressed, often with the possibility of ablation. Antiarrhythmic drugs require attention to ventricular function, conduction, proarrhythmic effects, and interactions. Electrical treatment should be accompanied by correction of predisposing conditions, such as significant regurgitation, obstruction, or atrial dilation. Treating only the episode without reassessing hemodynamics may leave the causes of recurrence unchanged.

Monomorphic ventricular tachycardia often uses slow-conduction isthmuses between scars and anatomical structures. Ablation can interrupt the circuit and reduce recurrences, but does not automatically eliminate every mechanism of sudden death. Mapping studies have established the possibility of identifying and treating these corridors, including through a substrate-based strategy. Decisions concerning a defibrillator consider previous cardiac arrest, tolerance of tachycardia, function, residual risk, and feasibility of ablation. In highly selected cases, management can be individualized at expert centers; it is incorrect to promise that a technically successful procedure always makes device protection unnecessary.

The timing of ablation relative to valve replacement requires joint planning. An isthmus near the pulmonary annulus or septal patch may become harder to reach after implantation of new material. If the history and risk assessment suggest a relevant substrate, the congenital heart specialist, electrophysiologist, and valve interventionist discuss whether to investigate it beforehand, treat it during surgery, or monitor it. This reasoning does not imply indiscriminate preventive ablation: the anatomical presence of a corridor does not prove that it conducts slowly or sustains tachycardia. The goal is to prevent independently planned procedures from creating foreseeable technical obstacles, while keeping invasive intervention proportionate. Demonstrating conduction block after ablation and subsequently reassessing the clinical status are more informative than simply delivering energy at a presumed critical site.

An implantable cardioverter-defibrillator provides protection against potentially fatal arrhythmias in appropriate patients, but entails risks of inappropriate shocks, infection, lead problems, and psychological impact. System choice considers the need for antitachycardia pacing, other pacing requirements, venous access, and anatomy. Young patients face a long lifetime of exposure to the device, so the balance of benefits and risks requires particularly clear discussion. A primary prevention indication is based on a combination of factors, not solely on the presence of repaired tetralogy. Programming and specialist follow-up are part of treatment, because the quality of protection also depends on management after implantation.

Physical activity is encouraged within limits appropriate to function, residual lesions, arrhythmias, and exercise response. Generalized restriction may promote deconditioning, weight gain, and reduced social participation. Conversely, indiscriminate approval of intense exercise disregards significant obstruction, dysfunction, or electrical instability. The prescription should describe feasible intensity and type of activity, including realistic progression and reassessment when the condition changes. Exercise testing helps base recommendations on observed capacity. Competitive sports, extreme environments, or occupations in which syncope would have serious consequences require specific assessment, distinct from advice to remain regularly active in everyday life.

Pregnancy requires assessment before conception. Outcomes may be favorable in many women with well-repaired Fallot and good function, whereas ventricular dysfunction, cyanosis, arrhythmias, or significant residual lesions increase complexity. Increased blood volume and cardiac output may unmask limited reserve; risk is therefore discussed according to current physiology, not the congenital label alone. Medications, prostheses, any anticoagulation, and the need for interventions before pregnancy are reviewed with a joint cardiology-obstetric team. Genetic counseling and fetal echocardiography address fetal risk, while the maternal plan includes delivery and the postpartum period, during which volume shifts remain important.

Individual prognosis results from the interaction of anatomy, quality of repair, residual loading, myocardial substrate, and sustained access to care. Contemporary surgical cohorts show favorable outcomes, but thirty-year estimates necessarily include operations performed in earlier eras. Comparisons between techniques must distinguish anatomical selection from effects of the technique itself. Surviving without reintervention is not always the best outcome if it means tolerating a damaging lesion for a prolonged period; a planned reintervention may preserve function and independence. The purpose of follow-up is to maintain a good life trajectory and identify the appropriate time to act, avoiding both premature procedures and delays that allow irreversible damage.

Early and late complications

Hypoxic complications of uncorrected tetralogy include severe spells, loss of consciousness, neurological injury, and metabolic deterioration. Risk depends on reduced pulmonary blood flow and the ability to compensate for inadequate arterial oxygen content. Dehydration, fever, and anemia relative to the degree of cyanosis may precipitate an already precarious balance. In patients with right-to-left shunting, thrombotic or infectious material may reach the systemic circulation without the normal pulmonary filter, contributing to embolic events or brain abscesses. New headache, persistent fever, focal deficits, or altered mental status therefore require prompt assessment and must not automatically be attributed to habitual cyanosis.

Secondary erythrocytosis may be accompanied by hemostatic abnormalities and iron deficiency, creating a complex balance between bleeding and thrombosis. Elevated hematocrit must be interpreted together with symptoms and hydration status. Unnecessary phlebotomy reduces oxygen-carrying capacity and may promote iron deficiency; specialist management distinguishes symptomatic hyperviscosity from disorders due to other causes. Anticoagulation is not automatic for cyanosis alone and requires a specific indication. This physiology is particularly relevant in unrepaired patients or those with significant cyanotic residual lesions, whereas it does not usually describe a patient with complete separation of the circulations and normal saturation.

In the postoperative period, low cardiac output syndrome may result from myocardial dysfunction, reduced filling, residual obstruction, a significant shunt, coronary problems, or arrhythmias. Peripheral signs, urine output, lactate, and venous saturation must be assessed together, because acceptable blood pressure does not guarantee adequate output. Bedside echocardiography looks for correctable mechanical causes, including significant effusion and regional abnormalities. Intensive support is tailored to the predominant mechanism: increasing contractility in the presence of dynamic obstruction or giving fluids without recognizing congestion may fail to resolve the problem. Persistent instability should prompt anatomical reassessment, not merely escalating support.

Postoperative arrhythmias may include junctional ectopic tachycardia, atrial tachyarrhythmias, and conduction disturbances. Temperature, catecholamines, electrolytes, and injury near the conduction system influence their occurrence. Loss of atrioventricular synchrony may be particularly unfavorable in a stiff right ventricle. Treatment combines correction of precipitating factors, drug strategies, and, when needed, pacing or hemodynamic support. Persistent atrioventricular block may require pacing; management also considers the possibility of recovery and risk of late recurrence. Rhythm must be documented precisely because tachycardias that appear similar on a monitor may require different interventions.

A residual ventricular septal defect may be small and inconsequential or may produce volume overload, hemolysis, or infection risk. Its significance depends on size, direction, flow ratio, and pressures, not simply the presence of a color Doppler jet. A small, high-velocity jet is not necessarily a large-volume shunt; conversely, a low-gradient communication may be important when pressures are close. When considering closure, margins, proximity to valves, conduction tissue, and the feasibility of percutaneous or surgical intervention are assessed. Benefit should address a concrete clinical consequence rather than merely eliminating every echocardiographic irregularity.

Residual or recurrent obstruction may occur in the infundibulum, valve, conduit, or pulmonary arterial branches. A progressively increasing gradient raises afterload and may promote hypertrophy, reduced reserve, and arrhythmias. In conduits, patient growth, calcification, and material degeneration play a role; distortion or scarring may contribute in the branches. Treatment does not necessarily require another complete repair: dilation, stenting, valve intervention, or targeted surgery is selected according to location and relationships. Mild residual obstruction may be tolerated, but describing it as beneficial because it limits regurgitation does not justify indefinitely accepting excessive right ventricular pressure or documented progression.

Chronic pulmonary regurgitation may remain clinically silent for a long time while the right ventricle dilates. An absence of edema or dyspnea at rest does not exclude significant overload; conversely, a large but stable, well-functioning chamber does not alone require immediate intervention. Clinical risk emerges from progression, end-systolic function, exercise capacity, and arrhythmic substrate together. The most important complication is not the number quantifying regurgitation, but deterioration in pump function and reserve. Follow-up must therefore describe the temporal relationship between the valvular lesion and ventricular response, rather than observing separately two physiologically connected phenomena.

Biventricular dysfunction represents a complex stage in which correcting the pulmonary valve alone may not be enough. Ischemia, persistent arrhythmias, residual pressure overload, tricuspid regurgitation, and acquired diseases are investigated; renal function, hepatic congestion, and nutritional status help quantify systemic consequences. Selected patients may require advanced strategies, including evaluation for circulatory support or transplantation, at centers experienced in congenital heart disease. Previous sternotomies, collateral vessels, immune sensitization, or complex vascular anatomy affect planning. Early recognition of an unfavorable trajectory permits these options to be considered before multiorgan damage reduces their feasibility.

Tricuspid regurgitation may result from annular dilation, ventricular changes, direct leaflet injury, or the presence of a pacing or defibrillator lead. Distinguishing the mechanism is essential: functional regurgitation may diminish after ventricular unloading, whereas a substantial structural defect may persist. The decision to combine tricuspid repair with pulmonary valve replacement therefore requires individual analysis and surgical discussion. Not every moderate jet justifies an additional intervention, but neither can every jet be ignored in the expectation of remodeling. Its effects on venous pressure and right ventricular function contribute to the assessment alongside echocardiographic severity.

Late ventricular tachycardias are often associated with reentry circuits, but the risk of sudden death is not limited to a single isthmus. Diffuse dysfunction, ischemia, electrical abnormalities, and hemodynamic deterioration may contribute. Scars remain even after technically successful pulmonary valve replacement, so reduced right ventricular volume does not automatically remove the indication for electrophysiological assessment or an already appropriate defibrillator. Prevention must integrate control of lesions, treatment of the substrate, and individualized protection. Arrhythmias may also signal advanced hemodynamic disease and should prompt reassessment of the heart defect as a whole.

Late atrial arrhythmias may arise from dilation, atrial scars, and aging of the substrate. Rapid atrial flutter or fibrillation reduces filling time and can abruptly worsen a previously compensated state. These arrhythmias also have thromboembolic implications that must be assessed according to anatomy and individual factors. Restoration of sinus rhythm does not complete the investigation: the mechanism, recurrence risk, and residual loading require evaluation. When anticoagulation is indicated, drug choice considers prostheses, renal function, interactions, and bleeding risk; congenital heart disease alone does not support uniform prescribing for everyone.

Infective endocarditis is particularly important in the presence of pulmonary prostheses, conduits, and intracardiac material. Persistent fever, bacteremia, an unexpected rise in gradient, or worsening regurgitation should raise suspicion. Vegetations on right-sided structures may be difficult to visualize from a single echocardiographic window, and the diagnostic pathway may require complementary techniques. Blood cultures before antibiotics, when clinical stability permits, and consultation with an experienced team help identify the organism and complications. Treatment depends on the microorganism, prosthesis, obstruction, embolic events, and infection control; a partial response to treatment does not exclude the need to remove infected material.

Infection prevention includes oral health, management of skin infections, and knowledge of the conditions requiring antibiotic prophylaxis under guidelines. Repaired tetralogy does not automatically confer the same lifelong indication in every patient: prostheses, cyanotic heart disease, and residual defects adjacent to prosthetic material are determining factors. Prophylaxis, when indicated for an at-risk procedure, does not replace daily hygiene or make persistent fever unimportant. Patients should know the type of prosthesis they have and maintain updated documentation, because risk may change after a new intervention even though the underlying congenital diagnosis remains the same.

Prosthetic dysfunction may result from structural degeneration, thrombosis, endocarditis, or mechanical problems. Rapidly developing stenosis calls for a different investigation from a slowly increasing gradient over years. For transcatheter valves and conduits, frame integrity, outflow tract geometry, and interactions with surrounding tissues must also be considered. Imaging compared with the baseline result helps distinguish a stable residual gradient from new deterioration. Treatment may include targeted medical therapy, another transcatheter procedure, or surgery, but first requires clarification of the mechanism; implanting another valve without recognizing active infection may leave the principal problem unresolved.

Aortopathy mainly manifests as dilation and, in some patients, aortic regurgitation. Significant progression may increase left ventricular loading and necessitate intervention, but dissection remains rare in available series. Egbe's analysis of the National Inpatient Sample documented this complication in a small proportion of hospital admissions involving adults with Fallot, with serious consequences when it occurred; a hospital-based denominator is not equivalent to incidence among patients followed as outpatients. Sudden chest pain or signs compatible with an acute aortic syndrome nevertheless require urgent assessment. Statistical rarity is no reason to ignore a suggestive clinical presentation.

Respiratory complications may persist in the variant with markedly dilated pulmonary arteries even after the intracardiac defect has been repaired. Bronchomalacia does not necessarily disappear immediately when compression is relieved, and infections or secretions may aggravate obstruction. Multidisciplinary planning with airway imaging and, when indicated, endoscopic assessment helps distinguish compression, malacia, and other causes. In patients with thoracic scarring or scoliosis, a restrictive component may add to cardiac limitation. Measuring respiratory function avoids attributing all reduced exercise capacity to a valve and helps develop a realistic rehabilitation program.

Noncardiac perioperative risk depends on current physiology. A well-compensated adult with mild residual lesions faces different issues from one with high right-sided pressure, dysfunction, and arrhythmias. Anesthesia, blood loss, changes in venous return, and positive-pressure ventilation may alter hemodynamic balance. Planning informs the team about the type of repair, prostheses, function, medications, and devices, with provision for appropriate monitoring. In persistently cyanotic heart disease, preventing air entry through venous lines is particularly important because of the risk of systemic embolism across the shunt. Preoperative consultation must translate anatomy into concrete operative recommendations rather than a generic fitness assessment.

Interruptions in care are a modifiable factor in late complications. An asymptomatic young person may not recognize the value of repeated checkups and may return only when arrhythmia or advanced failure develops. Effective transition includes education, scheduled appointments, access to records, and an identifiable care contact. Changes in residence, employment, or healthcare coverage may also interfere with continuity. The solution is not to indiscriminately increase testing, but to explain what each visit monitors and which changes require earlier contact. The ability to recognize one's own warning signs is a clinical skill developed over time.

The psychological impact may intensify when a new procedure is proposed, after a defibrillator shock, or during reproductive and employment decisions. Fear of activity, anticipatory anxiety, and adherence difficulties may impair quality of life even as cardiac parameters improve. Appropriate support helps distinguish necessary caution from excessive restriction without minimizing the burden of repeated interventions. Outcome assessment must therefore include social participation and perceived well-being alongside volumes, gradients, and freedom from events. In repaired Fallot, preserving health means sustaining both cardiovascular function and the possibility of living autonomously with a chronic condition.